[go: up one dir, main page]

BR9713514A - Novo uso de creatina - Google Patents

Novo uso de creatina

Info

Publication number
BR9713514A
BR9713514A BR9713514-3A BR9713514A BR9713514A BR 9713514 A BR9713514 A BR 9713514A BR 9713514 A BR9713514 A BR 9713514A BR 9713514 A BR9713514 A BR 9713514A
Authority
BR
Brazil
Prior art keywords
creatine
new use
heart
drug
new
Prior art date
Application number
BR9713514-3A
Other languages
English (en)
Inventor
Marco Anelli
Ettore Strumia
Original Assignee
Monsanto It Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11375243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9713514(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Monsanto It Spa filed Critical Monsanto It Spa
Publication of BR9713514A publication Critical patent/BR9713514A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: <B>"NOVO USO DE CREATINA"<D>. Descrição de um novo uso de creatina na preparação de uma droga para o tratamento de insuficiência cardíaca e/ou respiratória.
BR9713514-3A 1996-11-19 1997-11-10 Novo uso de creatina BR9713514A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002408A IT1298420B1 (it) 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria
PCT/EP1997/006225 WO1998022099A2 (en) 1996-11-19 1997-11-10 New use of creatine

Publications (1)

Publication Number Publication Date
BR9713514A true BR9713514A (pt) 2000-02-29

Family

ID=11375243

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713514-3A BR9713514A (pt) 1996-11-19 1997-11-10 Novo uso de creatina

Country Status (13)

Country Link
US (1) US6242490B1 (pt)
EP (1) EP0941081B1 (pt)
CN (2) CN1623534A (pt)
AR (1) AR009425A1 (pt)
AT (1) ATE230983T1 (pt)
BR (1) BR9713514A (pt)
DE (1) DE69718506T2 (pt)
DK (1) DK0941081T3 (pt)
ES (1) ES2191206T3 (pt)
IT (1) IT1298420B1 (pt)
PT (1) PT941081E (pt)
RU (1) RU2202345C2 (pt)
WO (1) WO1998022099A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3384539B2 (ja) * 1997-09-05 2003-03-10 義之 内田 喘息治療剤
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US9833427B2 (en) * 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US20030212130A1 (en) * 2000-09-14 2003-11-13 Miller Donald W. Creatine ester anti-inflammatory compounds and formulations
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US20040013732A1 (en) * 2001-09-25 2004-01-22 Michael Farber Starch-based delivery system for creatine
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20060025475A1 (en) * 2004-07-29 2006-02-02 Stanley Antosh Use of methyl pyruvate for the purpose of increasing muscle energy production.
US20060052448A1 (en) * 2004-09-04 2006-03-09 Mr. Stanley Antosh Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244534B1 (pt) 1973-06-27 1977-07-01 Biotherax Lab
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
AU3086897A (en) 1996-06-28 1998-01-21 Ipr-Institute For Pharmaceutical Research Ag Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc

Also Published As

Publication number Publication date
EP0941081B1 (en) 2003-01-15
WO1998022099A3 (en) 1998-07-09
EP0941081A2 (en) 1999-09-15
ES2191206T3 (es) 2003-09-01
DK0941081T3 (da) 2003-04-22
US6242490B1 (en) 2001-06-05
PT941081E (pt) 2003-04-30
WO1998022099A2 (en) 1998-05-28
AR009425A1 (es) 2000-04-12
IT1298420B1 (it) 2000-01-05
ITMI962408A1 (it) 1998-05-19
ITMI962408A0 (it) 1996-11-19
CN1623534A (zh) 2005-06-08
RU2202345C2 (ru) 2003-04-20
DE69718506D1 (de) 2003-02-20
DE69718506T2 (de) 2003-07-31
ATE230983T1 (de) 2003-02-15
CN1237904A (zh) 1999-12-08

Similar Documents

Publication Publication Date Title
BR9709915A (pt) Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto
BR9808348A (pt) Alimento medicinal para diabéticos
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
DE69732049D1 (de) Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika
BR9507656A (pt) Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BR9808227A (pt) Preparação medicinal contendo gás inerte lipofìlico
BR9711194A (pt) Uso de agente quelante clioquinol para a fabricação de uma composição farmacêutica para o tratamento de doença de alzheimer.
ATE231872T1 (de) Thiazolopyrimidinderivate
BR9807655A (pt) Uso de inibidores de lipase gastrintestinal.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
BR9808303A (pt) O uso de levobupivacaìna na cirurgia facial
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
RU95106680A (ru) Бициклические ароматические соединения и содержащие их фармацевтические и косметические композиции
BR9713514A (pt) Novo uso de creatina
EE04681B1 (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
FI962685L (fi) 2,3-diaryyli-1-bentsopyraanijohdannaisten käyttö lääkkeen valmistamiseksi luukadon ja osteoporoosin hoitamiseksi ja estämiseksi
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
ES2188742T3 (es) Trapidil para uso en la terapia de cuadros patologicos influenciables por la inmunomodulacion.
BR9808866A (pt) Moléculas retinóicas relacionadas à inibição da superprodução de endotelina-1 em doenças

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: PHARMACIA ITALIA S.P.A. (IT)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADES.